Kim Sablich - Jun 6, 2022 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Signature
By: /s/Adam Guttmann, as attorney in fact For: Kimbely Sablich
Stock symbol
JAZZ
Transactions as of
Jun 6, 2022
Transactions value $
-$842,429
Form type
4
Date filed
6/8/2022, 04:56 PM
Previous filing
Mar 11, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Tax liability -$263K -1.76K -5.8% $149.25 28.6K Jun 6, 2022 Direct F1
transaction JAZZ Ordinary Shares Sale -$211K -1.39K -4.86% $152.15 27.2K Jun 6, 2022 Direct F2
transaction JAZZ Ordinary Shares Sale -$29.6K -200 -0.74% $148.21 27K Jun 7, 2022 Direct F2, F3
transaction JAZZ Ordinary Shares Sale -$37.3K -250 -0.93% $149.22 26.7K Jun 7, 2022 Direct F2, F4
transaction JAZZ Ordinary Shares Sale -$86.3K -573 -2.14% $150.68 26.2K Jun 7, 2022 Direct F2, F5
transaction JAZZ Ordinary Shares Sale -$200K -1.32K -5.03% $151.87 24.9K Jun 7, 2022 Direct F2, F6
transaction JAZZ Ordinary Shares Sale -$15.4K -101 -0.41% $152.60 24.8K Jun 7, 2022 Direct F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
F2 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.05 to $148.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.12 to $149.70. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $150.32 to $151.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F6 Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $151.35 to $152.21. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.595 to $152.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.